| Literature DB >> 35805761 |
Hind Bitar1, Amal Babour1, Fatema Nafa2, Ohoud Alzamzami3, Sarah Alismail4,5.
Abstract
Despite the availability of online educational resources about human papillomavirus (HPV), many women around the world may be prevented from obtaining the necessary knowledge about HPV. One way to mitigate the lack of HPV knowledge is the use of auto-generated text summarization tools. This study compares the level of HPV knowledge between women who read an auto-generated summary of HPV made using the BERT deep learning model and women who read a long-form text of HPV. We randomly assigned 386 women to two conditions: half read an auto-generated summary text about HPV (n = 193) and half read an original text about HPV (n = 193). We administrated measures of HPV knowledge that consisted of 29 questions. As a result, women who read the original text were more likely to correctly answer two questions on the general HPV knowledge subscale than women who read the summarized text. For the HPV testing knowledge subscale, there was a statistically significant difference in favor of women who read the original text for only one question. The final subscale, HPV vaccination knowledge questions, did not significantly differ across groups. Using BERT for text summarization has shown promising effectiveness in increasing women's knowledge and awareness about HPV while saving their time.Entities:
Keywords: BERT; HPV; cervical cancer; machine learning; text summarization
Mesh:
Substances:
Year: 2022 PMID: 35805761 PMCID: PMC9265758 DOI: 10.3390/ijerph19138100
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1The flow diagram of the progress of the online randomized trial.
Participants’ characteristics.
| Characteristics | Group 1 ( | Group 2 ( | Total ( |
|---|---|---|---|
|
| |||
| Mean (SD) | 38.3 (12.8) | 37.4 (11.6) | 37.8 (12.2) |
|
| |||
| Caucasian | 94 (77.7) | 92 (76.0) | 186 (76.8) |
| Hispanic | 7 (5.8) | 12 (9.9) | 20 (8.2) |
| American Indian | 2 (0.8) | 2 (1.7) | 5 (2.1) |
| Asian | 4 (1.6) | 7 (5.8) | 11 (4.5) |
| African | 6 (2.5) | 7 (5.8) | 15 (6.2) |
| Other | 8 (3.3) | 1 (0.8) | 5 (2.1) |
|
| |||
| High school | 9 (7.4) | 11 (9.1) | 20 (8.2) |
| Associate degree | 15 (12.4) | 14 (11.6) | 29 (11.9) |
| Some collage, no degree | 22 (18.2) | 24 (19.8) | 46 (19) |
| Bachelor | 50 (41.3) | 48 (39.6) | 98 (40.5) |
| Master | 22 (18.2) | 22 (18.2) | 44 (18.2) |
| Doctorate | 3 (2.5) | 2 (1.7) | 5 (2.1) |
Group 1 = received the summarized text version; Group 2 = received the original text version.
General HPV knowledge and awareness at baseline.
| Items | Answers | Group 1 | Group 2 | Total | |
|---|---|---|---|---|---|
|
| Yes | 112 (92.6) | 116 (95.9) | 228 (94.2) | 0.449 |
| No | 8 (6.6) | 4 (3.3) | 12 (5.0) | ||
| Don’t know | 1 (0.8) | 1 (0.8) | 2 (0.8) | ||
|
| Yes | 94 (77.7) | 90 (74.4) | 184 (76.0) | 0.698 |
| No | 20 (16.5) | 25 (20.7) | 45 (18.6) | ||
| Don’t know | 7 (5.8) | 6 (5.0) | 13 (5.4) | ||
|
| Yes | 97 (80.2) | 103 (85.1) | 184 (76.0) | 0.449 |
| No | 21 (17.4) | 17 (14.0) | 45 (18.6) | ||
| Don’t know | 3 (2.5) | 1 (0.8) | 13 (5.4) |
HPV = human papillomavirus. Group 1 = received the summarized text version; Group 2 = received the original text version. a Chi-square test.
Comparison of general HPV knowledge after receiving the intervention between the two groups.
| Items a | Group 1 | Group 2 | |||||
|---|---|---|---|---|---|---|---|
| Correct | Incorrect | Do Not Know | Correct | Incorrect | Do Not Know | ||
|
| 114 (94.2) | 4 (3.3) | 3 (2.5) | 117 (96.7) | 3 (2.5) | 1 (0.8) | 0.335 |
|
| 104 (86.0) | 14 (11.6) | 3 (2.5) | 108 (89.3) | 12 (9.9) | 1 (0.8) | 0.435 |
|
| 99 (81.8) | 18 (14.9) | 4 (3.3) | 93 (76.9) | 25 (20.7) | 3 (2.5) | 0.341 |
|
| 117 (96.7) | 3 (2.5) | 1 (0.8) | 112 (92.6) | 9 (7.4) | 0 (0) | 0.154 |
|
| 114 (94.2) | 5 (4.1) | 2 (1.7) | 111 (91.7) | 6 (5.0) | 4 (3.3) | 0.450 |
|
| 88 (72.7) | 26 (21.5) | 7 (5.8) | 95 (78.5) | 26 (21.5) | 0 (0) | 0.295 |
|
| 97 (80.2) | 12 (9.9) | 12 (9.9) | 105 (86.8) | 15 (12.4) | 1 (0.8) | 0.166 |
|
| 83 (68.6) | 28 (23.1) | 10 (8.3) | 83 (68.6) | 31 (25.6) | 7 (5.8) | 1.00 |
|
| 98 (81.0) | 13 (10.7) | 2 (1.7) | 109 (90.1) | 11 (9.1) | 1 (0.8) | 0.061 |
|
| 101 (83.5) | 15 (12.4) | 5 (4.1) | 98 (81.0) | 19 (15.7) | 4 (3.3) | 0.614 |
|
| 110 (90.9) | 9 (7.4) | 2 (1.7) | 104 (86.0) | 16 (13.2) | 1 (0.8) | 0.228 |
|
| 98 (81.0) | 13 (10.7) | 10 (8.3) | 112 (92.6) | 5 (4.1) | 4 (3.3) | 0.008 |
|
| 108 (89.3) | 9 (7.4) | 4 (3.3) | 108 (89.3) | 11 (9.1) | 2 (1.7) | 1.000 |
|
| 79 (65.3) | 23 (19.0) | 19 (15.7) | 80 (66.1) | 32 (26.4) | 9 (7.4) | 0.892 |
|
| 78 (64.5) | 32 (26.4) | 11 (9.1) | 76 (62.8) | 35 (28.9) | 10 (8.3) | 0.789 |
|
| 83(68.6) | 29 (24.0) | 9 (7.4) | 47 (38.8) | 70 (57.9) | 4 (3.3) | 0.0001 |
Note: a Not all the 242 women answered the questions. b Chi-square test; T: Correct = 1, incorrect/don’t know = 0; F: Correct/don’t know = 0, incorrect = 1. Group 1 = received the summarized text version; Group 2 = received the original text version.
Comparison of HPV testing knowledge after receiving the intervention between the two groups.
| Items a | Group 1 | Group 2 | |||||
|---|---|---|---|---|---|---|---|
| Correct | Incorrect | Do Not Know | Correct | Incorrect | Do Not Know | ||
|
| 90 (74.4) | 25 (20.7) | 6 (5) | 90 (74.4) | 30 (24.8) | 1 (0.8) | 1.000 |
|
| 101 (83.5) | 8 (6.6) | 12 (9.9) | 103 (85.1) | 13 (10.7) | 5 (4.1) | 0.724 |
|
| 63 (52.1) | 40 (33.1) | 18 (14.9) | 69 (57) | 40 (33.1) | 12 (9.9) | 0.439 |
|
| 66 (54.5) | 44 (36.4) | 11 (9.1) | 75 (62) | 41 (33.9) | 5 (4.1) | 0.241 |
|
| 47 (38.8) | 42 (34.7) | 32 (26.4) | 75 (62) | 26 (21.5) | 20 (16.5) | 0.0001 |
|
| 53 (43.8) | 51 (42.1) | 17 (14) | 66 (54.5) | 48 (39.7) | 7 (5.8) | 0.095 |
Note: a Not all the 242 women answered the questions. b Chi-square test; T: Correct = 1, incorrect/don’t know = 0; F: Correct/don’t know = 0, incorrect = 1. Group 1 = received the summarized text version; Group 2 = received the original text version.
Comparison of HPV vaccination knowledge after receiving the intervention between the two groups.
| Items a | Group 1 | Group 2 | |||||
|---|---|---|---|---|---|---|---|
| Correct | Incorrect | Do not know | Correct | Incorrect | Do Not Know | ||
|
| 97 (80.2) | 17 (14) | 7 (5.8) | 92 (76) | 28 (23.1) | 1 (0.8) | 0.437 |
|
| 86 (71.1) | 24 (19.8) | 11 (9.1) | 98 (81) | 17 (14) | 6 (5) | 0.071 |
|
| 91 (75.2) | 28 (23.1) | 2 (1.7) | 83 (68.6) | 38 (31.4) | 0 (0) | 0.253 |
|
| 93 (76.9) | 22 (18.2) | 6 (5) | 92 (76) | 25 (20.7) | 4 (3.3) | 0.880 |
|
| 97 (80.2) | 15 (12.4) | 9 (7.4) | 99 (81.8) | 18 (14.9) | 4 (3.3) | 0.743 |
|
| 69 (57) | 23 (19) | 29 (24) | 79 (65.3) | 30 (24.8) | 12(9.9) | 0.187 |
|
| 91 (75.2) | 17 (14) | 13 (10.7) | 94 (77.7) | 19 (15.7) | 8 (6.6) | 0.649 |
Note: a Not all the 242 women answered the questions. b Chi-square test; T: Correct = 1, incorrect/don’t know = 0; F: Correct/don’t know = 0, incorrect = 1. Group 1 = received the summarized text version; Group 2 = received the original text version. HPV = human papillomavirus.
Independent sample t-test between groups 1 and 2.
| Item | Group |
| Mean (SD) | |
|---|---|---|---|---|
|
| 1 | 121 | 12.97 (2.69) | 0.282 |
| 2 | 121 | 12.87 (2.76) | ||
|
| 1 | 121 | 3.47 (1.52) | 0.017 |
| 2 | 121 | 3.95 (1.58) | ||
|
| 1 | 121 | 5.15 (1.42) | 0.586 |
| 2 | 121 | 5.26 (1.63) | ||
|
| 1 | 121 | 21.6 (4.74) | 0.449 |
| 2 | 121 | 22.09 (5.24) |
Note: HPV = human papillomavirus. T: Correct = 1, incorrect/don’t know = 0; F: Correct/don’t know = 0, incorrect = 1. a independent sample t-test. Group 1 = received the summarized text version; Group 2 = received the original text version.
ANCOVA Comparison of total HPV knowledge after the intervention between the two groups with adjustment for the baseline scores.
| Items | Mean a | Std. Error | F | |||
|---|---|---|---|---|---|---|
| Group 1 | Group 2 | Group 1 | Group 2 | |||
|
| 22.07 | 22.43 | 0.333 | 0.322 | 0.591 | 0.443 |
Note: HPV = human papillomavirus; Group 1 = received the summarized text version; Group 2 = received the original text version. a Adjusted for baseline score. Not all the 242 women answered the baseline questions.